Skip to main content

Animations

MJFF Publications

3881 - 3890 of 8471 Results
Title
Year
  • Year
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • Summary Details
    RESTRICTED
    Title: Next-Generation Diamond Electrodes for Neurochemical Sensing: Challenges and Opportunities
    Journal Name: Micromachines
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/mi12020128
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Optimization of Lipophilic Metalloporphyrins Modifies Disease Outcomes in a Rat Model of Parkinsonism
    Journal Name: The Journal of Pharmacology and Experimental Therapeutics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1124/jpet.120.000229
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Radiosynthesis, In Vitro and In Vivo Evaluation of [18F]CBD-2115 as a First-in-Class Radiotracer for Imaging 4R-Tauopathies
    Journal Name: ACS Chemical Neuroscience
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acschemneuro.0c00801
    Citation Count: 40
  • Summary Details
    OPEN
    Title: The Parkinson's Disease DNA Variant Browser
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.28488
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Analysis of voice as an assisting tool for detection of Parkinson's disease and its subsequent clinical interpretation
    Journal Name: Biomedical Signal Processing and Control
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.bspc.2021.102415
    Citation Count: 48
  • Summary Details
    OPEN
    Title: Characterizing Advanced Parkinson’s Disease: Romanian Subanalysis from the OBSERVE-PD Study
    Journal Name: Parkinson's Disease
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1155/2021/6635618
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Motor Progression in Early-Stage Parkinson's Disease: A Clinical Prediction Model and the Role of Cerebrospinal Fluid Biomarkers
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2020.627199
    Citation Count: 13
  • Summary Details
    RESTRICTED
    Title: The Membrane Interactions of Synuclein: Physiology and Pathology
    Journal Name: Annual Review of Pathology: Mechanisms of Disease
    Publisher: Annual Reviews
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1146/annurev-pathol-031920-092547
    Citation Count: 35
  • Summary Details
    RESTRICTED
    Title: N-terminal acetylation does not alter α-synuclein's interfacial properties
    Journal Name: International Journal of Biological Macromolecules
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.ijbiomac.2021.01.147
    Best OA location URL:
    Citation Count: 4
  • Summary Details
    RESTRICTED
    Title: Author Correction: The effect of LRRK2 loss-of-function variants in humans
    Journal Name: Nature Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/s41591-020-01185-6
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.